No. I don't believe that is the case.
The Namibian NOC put out this statement which is quite specific
https://www.facebook.com/NamOlympic/photos/a.828366073847470/4770073503010021/?type=3
In it they say that the athletes were subject to assessments under the WA Eligibility Regulations, which are here
https://www.worldathletics.org/download/download?filename=656101dc-7716-488a-ab96-59d37941e9ac.pdf&urlslug=C3.6%20-%20Eligibility%20Regulations%20for%20the%20Female%20Classification
That's a very specific statement, and the assessment is also specific:
3.8 The case will be assessed in accordance with the guidelines set out in Appendix 2 to
these Regulations. The standard procedure may be summarised as follows:
3.8.1 There will be an initial assessment by a suitably qualified physician,
involving an initial clinical examination of the athlete, and compilation of her
clinical and anamnestic data, as well as a preliminary endocrine
assessment.3.8.2 If it appears the athlete may be a Relevant Athlete, the World Athletics
Medical Manager will then anonymise the file and send it to the chair, who
will convene an Expert Panel to determine whether further assessment is
warranted as to whether the athlete is a Relevant Athlete.
3.8.3 If the Expert Panel considers that further assessment is warranted, the
athlete will then be referred to one of the specialist reference centres listed
at Appendix 3 to these Regulations for further assessment, in order to reach
a diagnosis of the cause of the athlete’s elevated levels of blood
testosterone, and to consider further the degree of the athlete’s androgen
insensitivity (if any).
3.8.4 The report of the specialist reference centre will then be sent back to the
Expert Panel for consideration.
Appendix 2 describes this more clearly:
1. This Appendix sets out an overall framework for the assessment of cases arising
under the Regulations. The specific procedure to be adopted in each case will
depend on the nature, timing and/or complexity of the case. For example, depending
on the circumstances of the case, the Level 1 and Level 2 Assessments may be
performed together, or the athlete may be referred directly to the Level 3 Assessment.
Level 1 Assessment – initial clinical examination and compilation of data and
preliminary endocrine assessment
2. When a case first arises for assessment under the Regulations, the first step will
normally be an initial clinical examination of the athlete and compilation of her clinical
and anamnestic data, together with a preliminary endocrine assessment (together, the
Level 1 Assessment), in order to (i) confirm that the athlete's blood testosterone level
is 5 nmol/L or greater; (ii) gather information to assist in diagnosing the cause of her
elevated level of blood testosterone; and (iii) gather information to assist in assessing
whether the athlete is androgen insensitive (and, if so, to what degree).
3. To the extent that such information has already been gathered by the athlete’s own
physician, and is provided by that physician (having obtained the athlete’s informed
consent) to the World Athletics Medical Manager for use in assessing the athlete’s
case under the Regulations, the World Athletics Medical Manager will not repeat the
process but will rely on that information, provided it appears adequate and reliable.
4. If not all of the necessary information has been gathered, however, the World Athletics
Medical Manager will refer the athlete to an appropriate examining physician, who
should be a gynaecologist, endocrinologist or pediatrician with extensive experience of
DSDs and other conditions leading to female hyperandrogenism.
8. For the preliminary endocrine assessment, urine and blood (serum) samples will be
collected from the athlete under conditions prescribed by the World Athletics Medical
Manager, for analysis by a laboratory approved by World Athletics.
a. The laboratory will analyse the athlete’s urine for at least the following hormones
and their urinary metabolites: testosterone, epitestosterone, androsterone,
etiocholanolone, 5α-androstanediol, 5β-androstanediol, dihydrotestosterone and
dehydroepiandrosterone sulphate.7
b. The laboratory will analyse the athlete’s blood (serum) to determine the
concentration of testosterone.5, 8
c. Depending on the circumstances of the case, to assist with diagnosis the World
Athletics Medical Manager may also decide to have the athlete’s blood
analysed for additional hormones/substances, including but not limited to
dihydrotestosterone, luteinizing hormone, follicle-stimulating hormone, estradiol,
prolactin, anti-mullerian hormone, inhibin B, 17-OH-Progesterone,
dehydroepiandrosterone sulfate, delta 4 androstenedione, and/or sex hormonebinding globulin.
9. The laboratory’s reports of the results of the above analyses, the report of the
examining physician in respect of the initial clinical examination of the athlete, and the
clinical and anamnestic data compiled, will be transmitted confidentially to the athlete’s
designated physician and to the World Athletics Medical Manager.
10. The World Athletics Medical Manager will review the results of the Level 1 Assessment
to decide whether there is sufficient information for the Expert Panel to carry out the
Level 2 Assessment.
Level 2 Assessment – assessment by an Expert Panel
11. Once the necessary information has been gathered and a blood testosterone
concentration above 5 nmol/L has been confirmed, the World Athletics Medical
Manager will send the file (in anonymised form) to the chair of the Expert Panel,9 who
will either review the case alone or choose at least three experts (which may include
him/herself) from the list at Appendix 1 to review the case.
12. The Expert Panel (whether one person or more) will review the athlete’s file to
determine whether further investigation is warranted as to whether the athlete meets
the following criteria
a. she has one of the following DSDs:
i. 5α-reductase type 2 deficiency;
ii. partial androgen insensitivity syndrome (PAIS);
iii. 17β-hydroxysteroid dehydrogenase type 3 (17β- HSD3) deficiency;
iv. ovotesticular DSD; or
v. any other genetic disorder involving disordered gonadal steroidogenesis;10
and
b. as a result, she has blood testosterone levels of 5 nmol/L or above; and
c. she has sufficient androgen sensitivity for those levels of testosterone to have a
material androgenising effect. To assess this third criterion, the Expert Panel will
look at the results of the clinical examination and the data collected as part of the
Level 1 Assessment in order to determine the nature and extent of the
androgenising effect, with the benefit of any doubt on this issue being resolved in
favour of the athlete.
14. If the Expert Panel considers that further investigation is warranted as to whether the
athlete meets the criteria to be a Relevant Athlete, then the Expert Panel will
recommend a full examination and diagnosis under level 3 (the Level 3 Assessment).
----
So the Level 3 Assessment Centres are in Stockholm, Nice, Hershey, Melbourne, Tokyo, Sao Paolo, and London.
It seems that therefore that what happened is a Level 1 medical assessment was performed, i.e.:
* an extensive hormone panel was taken including DHT, which a given T:DHT ratio would instantly confirm 5-ARD (Caster Semenya's condition), and hence conclusively that the athlete is XY with testes and lack of type-2 alpha-reductase
* the results of this were sent to the experts, in anonymous form, who concluded that the athletes are, in effect, unambiguously male.
By unambiguously male what I mean is that:
1) they have testes or ovotestes
2) they have normal male levels of testosterone
3) the doctor examined their bodies and found that they respond normally to testosterone, and there is no 'benefit of the doubt', that these athletes are androgen insensitive.
In contrast to the clear statement from the NNOC that these athletes failed what is effectively a sex test, and the fact that there is no mention of a level 3 referral to a specialist centre (which would happen if there was any question that these athletes were borderline in being female rather than male), we have the claim from the Abner Xoagub
that '“These ladies have XX chromosomes, they are females and conform to all female biological requirements,”
This is obviously a lie on at least the last point, because they have failed a sex test. Xoagub is not a doctor; rather a former boxing promoter, and I see no reason to believe his claim that they have XX chromosomes. It's of course possible that they have XX/XY chromosomes and ovotestes, but XX/XY is not the same as XX, so it seems to me the more reasonable assumption is that Xoagub is just talking nonsense, and we won't know the exact details of these athletes' conditions, but we can be sure they have normal male T as result of testes or ovotestes, and process it as normal humans do.